756526-00-8 Usage
Uses
Used in Pharmaceutical Industry:
Z-15-aMino-4,7,10,13-tetraoxapentadecacanoic acid is used as a building block for the synthesis of complex pharmaceutical compounds. Its unique structure and functional groups make it a versatile candidate for the development of new drugs with specific therapeutic properties.
Used in Chemical Synthesis:
In the field of chemical synthesis, Z-15-aMino-4,7,10,13-tetraoxapentadecacanoic acid can be used as a key intermediate for the preparation of various organic compounds. Its reactive functional groups can be further modified or used to form new chemical bonds, leading to the creation of novel molecules with potential applications in various industries.
Used in Material Science:
The unique structure of Z-15-aMino-4,7,10,13-tetraoxapentadecacanoic acid may also find applications in material science. Its properties, such as solubility and reactivity, could be exploited to develop new materials with specific characteristics, such as improved mechanical strength, thermal stability, or chemical resistance.
Used in Drug Delivery Systems:
Similar to the use of gallotannin in drug delivery systems, Z-15-aMino-4,7,10,13-tetraoxapentadecacanoic acid could be employed as a component in the development of novel drug delivery systems. Its unique structure and functional groups may allow for the creation of targeted drug delivery systems, improving the bioavailability and therapeutic outcomes of various pharmaceutical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 756526-00-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,6,5,2 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 756526-00:
(8*7)+(7*5)+(6*6)+(5*5)+(4*2)+(3*6)+(2*0)+(1*0)=178
178 % 10 = 8
So 756526-00-8 is a valid CAS Registry Number.
756526-00-8Relevant academic research and scientific papers
CONJUGATES OF A CELL-BINDING MOLECULE WITH CAMPTOTHECIN ANALOGS
-
Page/Page column 153, (2021/10/30)
Provided are conjugates of camptothecin analogs with a cell-binding molecule of formula (I), wherein R1, R2, R3, R4, R5, X, L, n, m, T and ----- are defined herein. It also provides methods of making the conjugates of camptothecin analogs to a cell-binding agent, as well as methods of using the conjugates in targeted treatment of cancer, infection, and immunological disorders.
PHARMACEUTICAL COMPOUNDS TARGETED BY MIF AFFINITY-TETHERED MOIETIES
-
Page/Page column 69, (2015/01/09)
There is disclosed a compound, a pharmaceutical composition and a method of treatment using a pharmaceutical composition comprising a tethering moiety that is capable of binding to a macrophage migration inhibitory factor (MIF) polypeptide, optionally linked to a linker moiety and further covalently bound to a drug moiety or imaging agent. More specifically, there is disclosed a genus of affinity-tethering moieties covalently bound to a drug moiety or imaging agent either directly or optionally via a linker moiety to covalently link the tethering moiety to a drug moiety. Without being bound by theory, the disclosed pharmaceutical compounds are targeted to cancer cells or immune cells via an affinity-tethering moiety that hitch-hikes to or into its target cell while bound to endogenous MIF.
